Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Zeta Global Reports 16th Straight “Beat and Raise” Quarter

NEW YORK--(BUSINESS WIRE)--Zeta Global Reports 16th Straight “Beat and Raise” Quarter

Will the continued "beat and raise" pattern affect the stock’s volatility profile or trigger technical chart patterns (e.g., breakouts, trendline support)? How does the updated guidance align with analysts’ consensus estimates and target price revisions? What impact might the earnings beat have on institutional and retail demand for ZETA shares in the short term?
Symbol: ZETA
Earnings
about 1 month ago
Read more businesswire

Incyte Announces Departure of Chief Financial Officer Christiana Stamoulis

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Announces Departure of Chief Financial Officer Christiana Stamoulis

Is there any indication that the departure is related to strategic shifts, such as restructuring, M&A activity, or partnership negotiations? Will the loss of the CFO affect investor sentiment or trigger any short‑term volatility in the stock? What impact, if any, might this have on Incyte’s credit facilities, loan covenants, or financing alternatives?
Symbol: INCY
Management
about 1 month ago
Read more businesswire

Janux Therapeutics Announces Clinical Milestone Achievement in TRACTr Collaboration With Merck

SAN DIEGO--(BUSINESS WIRE)---- $JANX--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying it...

What is the estimated market size for the TRACTr therapy and its potential long‑term impact on Janux's valuation? What are the projected patient enrollment rates and trial size, and could any challenges in enrollment delay timelines? How will this clinical milestone be incorporated into Janux's revised earnings forecasts and revenue projections?
Symbol: JANX
Clinical trials
about 1 month ago
Read more businesswire

Evolus Reports Second Quarter 2025 Financial Results and Provides Business Updates

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced its financial r...

How might this demand shock influence the company's long‑term growth strategy, including potential M&A activity? Does the company have plans to revive demand through new product launches, marketing campaigns, or distribution expansion? What is the likely reaction of institutional and retail investors to this earnings report and how might it affect short‑term price movements?
Symbol: EOLS
Earnings
about 1 month ago
Read more businesswire

Upstart Announces Results for Second Quarter 2025

SAN MATEO, Calif.--(BUSINESS WIRE)--Upstart Announces Results for Second Quarter 2025

How might the current macroeconomic environment (e.g., interest rates, housing market trends) influence Upstart's loan demand and risk profile moving forward? Did the results reveal any new strategic initiatives, product launches, or partnerships that could drive long‑term value? What is the cash flow situation—did the company generate positive operating cash flow or require additional financing?
Symbol: UPST
Earnings
about 1 month ago
Read more businesswire

SITE Centers Reports Second Quarter 2025 Results

BEACHWOOD, Ohio--(BUSINESS WIRE)--SITE Centers Reports Second Quarter 2025 Results

Given the reported sentiment score of 10, how might market participants interpret the tone of the release, and could this lead to short‑term price volatility? What is the management’s commentary on tenant credit quality and lease‑expiry profile, and how might that affect risk exposure? Are there any macro‑economic factors (e.g., interest‑rate environment, supply‑chain demand for industrial space) addressed in the release that could influence forward‑looking expectations?
Symbol: SITE
Earnings
about 1 month ago
Read more businesswire

Axon jumps 16% after TASER maker tops results and boosts outlook on security needs

Axon Enterprise's stock popped 16% after the TASER maker topped Wall Street's estimates and boosted its outlook due to robust demand for its security solutions.

What’s the probability that the market will price‑in the higher outlook now versus waiting for next‑quarter results? How could macro‑economic factors (e.g., government spending cycles, public‑safety budget trends) influence Axon’s longer‑term outlook? What is the expected impact of this earnings beat on institutional and retail analyst sentiment and future coverage?
Symbol: AXON
Earnings
about 1 month ago
Read more cnbc_tech

Palantir stock pops 8% after blowout quarter driven by AI, efficiency demand

Palantir shares popped more than 8% after the software analytics provider lifted its full-year outlook, benefitting from ongoing AI tailwinds.

Is the stock’s 8% price pop fully justified or is there still upside potential? What potential regulatory or data‑privacy risks could affect Palantir’s AI products? How does the company's cash flow and liquidity position support the expanded outlook?
Symbol: PLTR
Earnings
about 1 month ago
Read more cnbc_tech

Coinbase shares slide Tuesday as crypto play takes double-digit fall from July record

Shares of the cryptocurrency trading platform have collapsed since notching a record on July 18.

How might the broader market environment (e.g., USD strength, risk appetite) influence the recovery timeline? What are the key technical support and resistance levels for COIN after this slide? Could this trend trigger stop‑loss orders or forced liquidations in leveraged positions?
Symbol: COIN
Stocks
about 1 month ago
Read more cnbc_tech

Advanced Energy Reports Second Quarter 2025 Results

DENVER--(BUSINESS WIRE)--Advanced Energy Industries, Inc. (Nasdaq: AEIS), a global leader in highly engineered, precision power conversion, measurement, and control solutions, announced financial r...

How might the Q2 results influence institutional sentiment and analyst coverage for AEIS? What is the outlook for capex and R&D spending in the next quarter, and how might that impact earnings forecasts? Are there any risks or headwinds—such as supply chain constraints or macro‑economic factors—that could affect future results?
Symbol: AEIS
Earnings
about 1 month ago
Read more businesswire